Familial Eosinophilic Cellulitis
Synonyms of Familial Eosinophilic Cellulitis
- Eosinophilic Cellulitis
- Granulomatous Dermatitis with Eosinophilia
- Wells syndrome
- No subdivisions found.
Familial eosinophilic cellulitis is a rare skin disorder. It is characterized by raised, red, swollen, and warm areas of skin, in a flame-shaped pattern with associated pain. The exact cause of the disease is unknown. However, bites of spiders, bees, mites, fleas, or ticks (arthropods) are often associated with this skin condition.
Familial eosinophilic cellulitis is a rare skin disorder. It sometimes occurs as an exaggerated response to bites of spiders, bees, fleas, ticks, or mites (arthropods), or it may have other causes such as surgery or drugs. The skin of the person will develop flame shaped patterns of raised, swollen, red areas that are warm to the touch. The episodes usually come on rapidly. Often, familial eosinophilic cellulitis will recur suddenly over a period of years with swelling and redness developing for no apparent reason. The attack may last up to six weeks and may continue to recur for years.
Large areas of skin may be affected and testing shows microscopic changes of the tissue. An abnormal number of white blood cells (eosinophils) are found in the red and swollen areas of skin, underlying fat, and usually in the blood. Skin blistering has also been known to develop.
The exact cause of familial eosinophilic cellulitis is still not known. Some scientists believe that there may be an autoimmune basis for the disorder. Autoimmune disorders are caused when the body's natural defenses (antibodies, lymphocytes, etc.), against invading organisms suddenly begin to attack perfectly healthy tissue.
Familial eosinophilic cellulitis affects males and females in equal numbers. The disorder is more often found in adults, but it may strike children as well.
Symptoms of the following disorders can be similar to those of familial eosinophilic cellulitis. Comparisons may be useful for a differential diagnosis:
Cellulitis is characterized by inflamed tissue of the skin. Often the skin becomes red, swollen, and painful, over a large area. There may be accompanying chills and fever. This disorder can be caused by either Group A beta-hemolytic streptococci, or in older persons it is sometimes caused by Group G streptococci.
Anaphylaxis is an extreme allergic reaction that can be caused by a person's hypersensitivity to drugs, insect venom, fish, nuts, and other substances. There is often extreme swelling, itching, flushing, hives, and other physical reactions to a particular substance. These reactions can often be life-threatening. (For more information on this disorder, choose "Anaphylaxis" as your search term in the Rare Disease Database.)
Contact dermatitis is a common allergic disorder characterized by skin inflammation and blisters. Redness, swelling, oozing, crusting, scaling, burning pain and usually itching are common. (For more information on this disorder choose "Contact Dermatitis" as your search term in the Rare Disease Database.)
Standard treatment of familial eosinophilic cellulitis may consist of administration of steroid drugs. However, the disorder often resolves itself after a number of weeks. Other treatment is symptomatic and supportive.
Research on Autoimmune diseases is continuing to determine why these disorders occur and how to treat them. For more information about this research contact the agencies listed in the Resources section of this report.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Organizations related to Familial Eosinophilic Cellulitis
Davis MDP, Leiferman KM. Familial Eosinophilic Cellulitis (NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:99.
Champion RH, Burton JL, Ebling FJG. Eds. Textbook of Dermatology. 5th ed. Blackwell Scientific Publications. London, UK; 1992.
Habif TP. Ed. Clinical Dermatology. 2nd ed. The C.V. Mosby Company. St. Louis, MO; 1990.
Holme SA, McHenry P. Nodular presentation of eosinophilic cellulitis (Wells' syndrome). Clin Exp Dermatol. 2001;26:677-79.
Weiss G, Shemer A, Confino Y, et al. Wells' syndrome: report of a case and review of the literature. Int J Dermatol. 2001;40:148-52.
Delaporte E. [From Wells syndrome to "eosinophilic disease"] Ann Dermatol Venereol. 2001;128
(3 Pt 1):207-11.
Moossavi M, Mehregan DR. Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol. 2003;42:62-67.
Tsuji Y, Kawashima T, Yokota K, et al. Wells' syndrome as a manifestation of hypereosinophilic syndrome. Br J Dermatol. 2002;147:811-12.
Herr H, Koh JK. Eosinophilic cellulitis (Wells' syndrome) successfully treated with low-dose cyclosporine. J Korean Med Sci. 2001;16:664-68.
Seckin D, Demirhan B. Drugs and Wells' syndrome: a possible causal relationship? Int J dermatol. 2001;40:138-40.
FROM THE INTERNET
Brown J, Schwartz RA. Wells Syndrome (Eosinophilic Cellulitis). eMedicine. Last Updated: August 20, 2002:12 pp.
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
Copyright ©1994, 2003, 2007, 2009
Report last updated: 2009/05/14 00:00:00 GMT+0
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.